BeaujeanF.SergierJ.M.le ForestierC.DuedariN.: Leucocyte depletion of red cell concentrates by filtration: Influence of blood product temperature.Vox Sang, 62: 242–243, 1992.
2.
LedentE.BerlinG.: Inadequate white cell reduction by bedside filtration of red cell concentrates.Transfusion, 34: 765–768, 1994.
3.
LedentE.BerlinG.: Factors influencing white cell removal from red cell concentrates by filtration.Transfusion, 36: 714–718, 1996.
4.
HeddleN.TanM.KlamaL.ShroederJ.: Factors affecting cytokine production in platelet concentrates.Transfusion, 34: 67S, 1994.
5.
CurrieL.M.HarperJ.R.AllanH.ConnorJ.: Inhibition of cytokine accumulation and bacterial growth during storage of platelet concentrates at 4 °C with retention of in vitro functional activity.Transfusion, 37: 18–24, 1997.
6.
MuylleL.LaekemanG.HermanA.G.PeetermansM.E.: Histamine levels in stored platelet concentrates: relationship to white cell content.Transfusion, 28: 226–228, 1988.
7.
FriedM.R.EastlundT.ChristieR.MullinG.T.KeyN.S.: Hypotensive reactions to white cell-reduced plasma in a patient undergoing angiotensin-converting enzyme inhibitor therapy.Transfusion, 36: 900–903, 1996.
8.
MairB.LeparcG.F.: Hypotensive reactions associated with platelet transfusions and angiotensin-coverting enzyme inhibitors.Vox Sang, 74: 27–30, 1998.
9.
BelloniM.AlghisiA.BettiniC.SoliM.ZampieriL.: Hypotensive reactions associated with white cell reduced apheresis platelet concentrates in patients not receiving ACE inhibitors.Transfusion, 38: 412–415, 1998.
10.
FisherM.ChapmanJ.R.TingA.MorrisP.J.: Alloimmunization to HLA antigens following transfusion with leukocyte-poor and purified platelet suspensions.Vox Sang, 49: 331–335, 1985.
11.
PetranyiG.G.PadanyiA.HoruzskoA.RethyM.GyodiE.PernerF.: Mixed lymphocyte culture: evidence that pretransplant transfusion with platelets induces FcR and blocking antibody production similar to that induced by leukocyte transfusion.Transplantation, 45: 823–824, 1988.
12.
BlajchmanM.A.: The effect of leukodepletion on allogeneic donor platelet survival and refractoriness in an animal model.Semin Hematol, 28: 14–17, 1991.
13.
EngelfrietC.P.van LoghemJ.J.: HL-A in connection with blood transfusion.Haematologia, 8: 267–272, 1974.
14.
HillyerC.D.EmmensR.K.Zago-NovarettiM.BerkmanE.M.: Methods for the reduction of transfusion-transmitted cytomegalovirus infection: filtration versus the use of seronegative donor units.Transfusion, 34: 929–934, 1994.
15.
HillyerC.D.SyndmanD.R.BerkmanE.: The risk of cytomegalovirus infection in solid organ and bone marrow transplant recipients: transfusion of blood products.Transfusion, 30: 659–666, 1990.
16.
Von LaerD.Meyer-KoenigU.SerrA.FinkeJ.KansL.FauserA.A.Neumann-HaefelinD.BruggerW.HufertF.T.: Detection of cytomegalovirus DNA in CD34+ cells from blood and bone marrow.Blood, 86: 4086–4090, 1995.
17.
LarssonS.Soderberg-NauclerC.WangF-Z, MollerE.: Cytomegalovirus DNA can be detected in peripheral blood mononuclear cells from all seropositive and most seronegative healthy blood donors over time.Transfusion, 38: 271–278, 1998.
18.
YomtovianR.LazarusH.M.GoodnoughL.T.HirschlerN.V.MorrisseyA.M.JacobsM.R.: A prospective microbiologic surveillance program to detect and prevent the transfusion of bacterially contaminated platelets.Transfusion, 33: 902–909, 1993.
19.
BlajchmanM.A.: Bacterial contamination of blood products and the value of pre-transfusion testing.Immunol Invest, 24: 163–170, 1995.
20.
SiegelS.E.LundeM.N.GeldermanA.H.: Transmission of toxoplasmosis by leukocyte transfusion.Blood, 37: 388–394, 1971.
21.
EsmondeT.F.WillR.G.SlatteryJ.M.KnightR.Harries-JonesR.deSilvaR.MatthewsW.B.: Creutzfeldt-Jakob disease and blood transfusion.Lancet, 341: 205–207, 1993.
